Table 2.
cfNGS Test Profile
| Total cfNGS tests obtained | n = 142 | % | |
|---|---|---|---|
| Primary Testing Indication | |||
| Clinical symptoms suggestive of infection | 68 | 47.9% | |
| Focal imaging finding | 38 | 26.8% | |
| Infection monitoring | 15 | 10.6% | |
| Immunocompromised | 9 | 6.3% | |
| Validation of conventional testing | 6 | 4.2% | |
| Elevated inflammatory markers | 3 | 2.1% | |
| Suspected rheumatologic process | 3 | 2.1% | |
| Median hospital day sent (IQR) | 6 | (3–28.75) | |
| Hours to results | |||
| Mean (SD) | 85.7 | (38.9) | |
| Median (IQR) | 72 | (48–105) | |
| Mode | 48 | ||
| Results | n | % | |
| Positive | 105 | 73.9% | |
| Single organism | 46 | ||
| Multiple organisms | 59 | ||
| Negative | 37 | 26.1% | |